Dr. Lindsay McNair to Speak at CenterWatch and iiBIG 2nd Annual Forum on Optimizing Clinical Research Performance

PRINCETON, N.J., Sept. 16, 2014 – WIRB-Copernicus Group (WCG), the world’s largest provider of regulatory and ethical review services for clinical research, announced today that Lindsay McNair, MD, MPH, MSB, its chief clinical research officer and president, consulting services, will be speaking at the CenterWatch and iiBIG 2nd Annual Forum on Optimizing Clinical Research Performance being held Sept. 15-16 in Boston, MA.

At this year’s forum, Dr. McNair will join industry professional Bonnie A. Brescia, founding principal of BBK Worldwide, for a discussion on “Engaging Patients Via Data Sharing.” The presentation will take place on Sept. 16 at 10:45am EDT during Break-out Track A: Innovations and Global Strategies Across the Clinical Research Enterprise in Room A201.

“Maintaining participant engagement through effective communications is a vital piece of the clinical research process,” said Dr. McNair. “It is our goal to focus on patient engagement from before the study even begins, all the way through to completion when study results are returned to participants. Establishing effective patient communications in each phase of a study is critical.”

Dr. McNair has more than 15 years’ experience providing medical guidance on clinical development strategies and study designs for new drugs. She has delivered medical oversight for all phases of clinical studies in a variety of therapeutic areas, including multiple oncology indications, hepatitis C, psoriasis and multiple sclerosis.

For more information about this year’s CenterWatch and iiBIG conference, please visit: http://www.iibig.com/conferences/P1403/overview.html.

About The WIRB-­‐Copernicus Group
The WIRB-Copernicus Group (WCG) is the world’s largest and most trusted provider of regulatory and ethical review services for human research. The pioneer of independent ethical review, WCG continues to drive ingenuity in the clinical research space. Today, WCG’s solutions are built upon the foundation of ethical review, but have grown to include a suite of complementary services and technologies that expand the capabilities of the modern research professional. WCG delivers transformational solutions that stimulate growth, foster compliance, and maximize efficiency for those who perform clinical trials.

WCG is proud to serve the individuals on the frontlines of science and medicine, and the organizations that strive to develop new products and therapies to improve the quality of human health. It is our role to empower them to accelerate advancement, while ensuring that the risks of progress never outweigh the value of human life.

For more information, please visit www.wcgclinical.com.

Download the Press Release
[wpdm_package id=’2379′]